Hypertension Registry of "Hypertension Prevention and Control Initiative in China"

Last updated: February 27, 2020
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Williams Syndrome

Circulation Disorders

Stress

Treatment

N/A

Clinical Study ID

NCT04289701
2019-ZX20
  • Ages > 18
  • All Genders

Study Summary

Hypertension is the leading preventable risk factor of cardiovascular disease globally and in China. Unparalleled to remarkable increase of hypertension burden in China, blood pressure(BP) control is inadequate. A political public health project, "Hypertension Prevention and Control Initiative in China(Chronic Disease Demonstration District Construction)", was initiated in October 2019 for explore a feasible and reproducible archetype for hypertension management and to improve the registration, management, treatment and control rates of hypertension in China. The project is designed to consecutively implement health service strategies in 40 pilot counties covering 31 provinces and around 200,000 hypertension patients in mainland China, via the National Medical Alliance for Hypertension(NMAH). The Hypertension Registry study aims to registry, follow up and observe the clinical features, treatment, blood pressure control and outcomes of all hypertension patients managed in the "Hypertension Prevention and Control Initiative in China" project.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥ 18 years.

  2. Residing in the local administrative area for at least 6 months.

  3. Hypertension：defined as systolic blood pressure (SBP) ≥140 mmHg and/or /diastolicblood pressure (DBP) ≥90 mmHg and/or use of antihypertensive medication within twoweeks.

  4. Informed consent.

Exclusion

Exclusion Criteria:

  1. patients under pregnancy or lactation.

  2. patients with severe liver or renal diseases.

  3. patients with history of malignant tumor.

  4. patients with mental illness that impair their consent.

Study Design

Total Participants: 200000
Study Start date:
October 08, 2019
Estimated Completion Date:
December 30, 2024

Study Description

Objective: The study aims to investigate the clinical features, treatment, blood pressure control and outcomes of hypertension patients managed in the "Hypertension Prevention and Control Initiative in China" project.

Study Type: A national, multicenter, observational, prospective cohort study.

Study Design: The cardinal contents of this registry study are as follows:

Introduce the Digital Information System and train in completing case report forms.

Collect sociodemographic information, lifestyle behaviors, self-reported personal medical history, BP, anthropometric measurements, medication at registration, laboratory investigations of hypertension patients managed in the "Hypertension Prevention and Control Initiative in China" project. Build a baseline database of hypertension patients.

Gather the follow up information including general, clinical, therapeutic, prognostic data of all recruits at 3-month intervals over 2 years and build up the follow-up database.

Data management, quality control and statistic analysis: Digital Information Platform for data capture, document and cloud computing has been built and the investigators will manage and analyze data in align with key indicators. The investigators have invited professional statistic analysts to assist analyzing data and a third party to supervise data quality.

Ethics: The Ethics Committee of Fuwai Hospital approved this study. Informed consents before patient enrollment are required.

Connect with a study center

  • The First Affliated Hospital of Anhui Medical University

    Hefei, Anhui 230022
    China

    Site Not Available

  • Beijing Shunyi District Hospital

    Beijing, Beijing 101300
    China

    Active - Recruiting

  • Chinese Academy of Medical Sciences，Fuwai Hospital

    Beijing, Beijing 100037
    China

    Active - Recruiting

  • First affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang 150001
    China

    Active - Recruiting

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan 410013
    China

    Site Not Available

  • The second affiliated hospital of Baotou medical college

    Baotou, Inner Mongolia 014030
    China

    Site Not Available

  • The Second Affilated Hospital Of Nanchang University

    Nanchang, Jiangxi 330046
    China

    Site Not Available

  • Yinchuan First People's Hospital

    Yinchuan, Ningxia 750010
    China

    Site Not Available

  • First Affiliated Hospital, Xian Jiaotong University

    Xi'an, Shanxi 710061
    China

    Site Not Available

  • Teda International Cardiovascular Hospital

    Tianjin, Tianjin 300457
    China

    Site Not Available

  • FuWai YunNan Cardiovascular Hospital

    Kunming, Yunnan 650032
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.